Coxagen

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCoxagen

Drug Alias Namepulmonary hypertension gene therapy (geneRx+/Aradigm)prostaglandin synthase gene therapy (geneRx+/Aradigm)COX gene therapy (geneRx+/Aradigm)

ClassificationBiologics

Mechanisms of ActionProstaglandin E2 agonistsCyclooxygenases modulatorsProstanoid IP receptor agonists

TargetsProstaglandin E2Prostanoid IP receptorCyclooxygenases

Therapy Area/IndicationsHypertension

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGenerx+

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAradigm Corp Generx+

Active IndicationsN/A

Inactive IndicationsHypertension

Other Information

ATC CodeN/A